Indication
For treatment of adult patients with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis (ATTRv).
Medicine details
- Medicine name:
- eplontersen (Wainzua)
- SMC ID:
- SMC2755
- Pharmaceutical company
- AstraZeneca UK Ltd
- BNF chapter
- Central nervous system
- Submission type
- Abbreviated
- Publication due date:
- 07 April 2025